AKTS Earnings

Quarterly EPS
$-0.25
Q4 2023
$-0.28
Q1 2024
$-0.21
Q2 2024
$-0.26
Q3 2024
$-0.91
Q4 2024
$-0.04
Q1 2025
$-0.38
Q1 2026
$-0.44
Q2 2026
Latest Revenue3.4M
Latest Net Income-24144000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.443.4M-24144000-54.9%-69.2%
Q1 2026-$0.383.2M-18325000-54.0%-81.0%
Q1 2025-$0.049.0M-6420000+28.9%+85.7%
Q4 2024-$0.915.9M-108803000-29.7%-264.0%
Q3 2024-$0.267.5M-23308000+2.1%-13.0%
Q2 2024-$0.217.0M-15711000+19.6%-10.5%
Q1 2024-$0.287.0M-20129000+25.8%+15.2%
Q4 2023-$0.258.3M-17765000+60.1%+10.7%
Q3 2023-$0.237.4M-15545000
Q2 2023-$0.195.9M-11156000
Q1 2023-$0.335.6M-19091000
Q4 2022-$0.285.2M-16274000
Aktis Oncology (AKTS) — Earnings